Anaemia On Demand Webinars
- Disclaimer:
- MEDICE UK has organised and funded this promotional webinar, it is intended for UK healthcare professionals only. MEDICE UK products are discussed at this meeting.
- Licensed indication:
- Vafseo®▼(vadadustat) is indicated for the treatment of symptomatic anaemia associated with CKD in adults on chronic maintenance dialysis.
- Vafseo Prescribing information can be found at this link: Vafseo prescribing information:
- Reporting Adverse Events:
- ▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to MEDICE UK on 020 4582 2845, pv-uk@medice.co.uk